(Rac) -Cemsidomide
(Rac) -Cemsidomide ((Rac) -CFT7455) is the racemate of Cemsidomide with antitumor activity[1]. Cemsidomide is a ubiquitin ligase pathway Ikaros/Aiolos degrader with molecular glue activity. Cemsidomide has a GI50 of 0.05 nM for NCIH929.1 cells.
Product Specifications
CAS Number
2504233-68-3
Product Name Alternative
(Rac) -CFT7455
UNSPSC
12352005
Target
Molecular Glues
Type
Reference compound
Related Pathways
PROTAC
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/rac-cemsidomide.html
Concentration
10mM
Purity
98.52
Solubility
DMSO : 62.5 mg/mL (ultrasonic; warming; heat to 60°C)
Smiles
O=C1N(C2C(NC(CC2)=O)=O)C3=CC=C(C4=CC=CC1=C43)CC5=CC=C(C=C5)CN6CCOCC6
Molecular Formula
C28H27N3O4
Molecular Weight
469.53
References & Citations
[1]David Proia et al. Advantageous therapies for disorders mediated by ikaros or aiolos. WO2022032132A1 (compound 5) |[2]James A. Henderson, et al. Abstract LB007: CFT7455: A novel, IKZF1/3 degrader that demonstrates potent tumor regression in IMiD-resistant multiple myeloma (MM) xenograft models. Cancer Res (2021) 81 (13_Supplement) : LB007.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS2133667-01 0.1 mL
FITC Linked Monoclonal Antibody to Ribonuclease A3 (RNASE3)
Sign In for Pricing
View Details MBS2133667-02 0.2 mL
FITC Linked Monoclonal Antibody to Ribonuclease A3 (RNASE3)
Sign In for Pricing
View Details